A Phase IIa, Randomized, Double Blinded, Placebo Controlled, Dose Finding Study for Single Dose Administration of TLC599 in Patients With Osteoarthritis (OA) of Knee
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 12 Jan 2018
At a glance
- Drugs Dexamethasone (Primary)
- Indications Osteoarthritis
- Focus Therapeutic Use
- Sponsors Taiwan Liposome Company
- 08 Jan 2018 Planned End Date changed from 1 Jul 2018 to 1 Nov 2018.
- 08 Jan 2018 Planned primary completion date changed from 1 Apr 2018 to 1 Aug 2018.
- 08 Jan 2018 Status changed from recruiting to active, no longer recruiting.